MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific Operating Cash Flow 2011-2026 | TMO
Annual Operating Cash Flow Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.82 B | 8.67 B | 8.41 B | 9.15 B | 9.31 B | 8.29 B | 4.97 B | 4.54 B | 4 B | 3.26 B | 2.94 B | 2.73 B | 2.01 B | 2.04 B | 1.69 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.31 B | 1.69 B | 5.32 B |
Quarterly Operating Cash Flow Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 723 M | - | - | 1.25 B | - | - | 729 M | - | 5.67 B | - | 2.2 B | - | 6.86 B | - | 1.98 B | - | 4.95 B | 2.24 B | 356 M | - | 3.06 B | 1.94 B | 649 M | - | 2.74 B | 1.52 B | 78 M | - | 2.14 B | 1.21 B | 361 M | - | 2.05 B | 1.25 B | 335 M | - | 1.59 B | 845 M | 80 M | - | 1.67 B | 990 M | 101 M | - | 1.28 B | 777 M | 298 M | - | 1.38 B | 900 M | 392 M | - | 1.05 B | 693 M | 339 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.86 B | 78 M | 1.53 B |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 115.6 | 0.06 % | $ 35.1 B |  USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 24.8 | 1.39 % | $ 689 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
42 M | $ 21.22 | -0.05 % | $ 1.13 B | USA |
 |
Illumina
ILMN
|
837 M | $ 127.82 | -0.05 % | $ 20.3 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 15.81 | -3.07 % | $ 478 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
390 M | $ 84.53 | 0.24 % | $ 5.7 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 170.09 | 0.19 % | $ 8.43 B | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 417.28 | 1.64 % | $ 12 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 89.33 | 0.47 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 7.17 | 1.7 % | $ 299 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.75 | 0.05 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.15 | 0.7 % | $ 4.94 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.07 | -0.93 % | $ 382 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 101.57 | -0.59 % | $ 8.38 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 263.9 | 0.06 % | $ 22 B | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.65 | 0.95 % | $ 61.9 M | Irlanda |
 |
Celcuity
CELC
|
-153 M | $ 123.04 | 1.66 % | $ 5.75 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 60.76 | -0.3 % | $ 3.63 B | USA |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.57 | 3.44 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.76 | -0.42 % | $ 441 M | USA |
 |
Natera
NTRA
|
-432 M | $ 204.88 | 0.55 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 196.9 | 0.35 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
583 M | - | -0.91 % | $ 14.7 B | USA |